Marc Carrier: TRIM-Line Trial Evaluates VTE Prevention in Cancer
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Thrombosis and Haemostasis, adding:
“An important knowledge gap: patients with cancer and a central venous catheter face an increased risk of venous thromboembolism, yet definitive evidence to support routine thromboprophylaxis after catheter insertion is lacking.
TRIM-Line is an ongoing randomized trial comparing rivaroxaban 10 mg daily with placebo for 90 days to determine whether prophylaxis reduces VTE with an acceptable bleeding risk.
We have enrolled 500 Canadian patients!
We are planning to open sites in France, Saudi Arabia and Italy.”
Title: Primary Thromboprophylaxis in Patients with Malignancy and Central Venous Catheters: TRIM-Line Randomized Controlled Trial—Design and Rationale
Authors: Tzu-Fei Wang, Rick Ikesaka, Isabelle Mahé, Danny Hill, Catherine Sperlich, Vicky Tagalakis, Sudeep Shivakumar, Blair Leonard, Andrea Cervi, Philip G. Kuruvilla, Fréderic Larose, Davide Matino, Steffan Frosi Stella, Chantal Séguin, Abdulrahman Al Raizah, Grégoire Le Gal, Deborah M. Siegal, Aurélien Delluc, Ranjeeta Mallick, Alejandro Lazo-Langner, Cynthia Wu, Dennis Christopher, Marcello Di Nisio, Walter Ageno, Bashour Yazji, Marc Carrier

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines